FAQ
During the first wave, people who tested positive for H1NI flu generally experienced mild symptoms, much like seasonal flu, and recovered after a few days without treatment. However, some people became very ill and developed severe respiratory problems. The elderly, pregnant women or those with immuno-suppressed conditions were more at risk. What we are seeing now, with the start of the second wave in other countries, is that there is a higher mortality rate with otherwise healthy young women.
There is some data to support the notion that the seasonal flu shot offers some protection. However, the annual vaccine was under development before the emergence of the H1N1 flu virus, so production of H1N1 vaccines were put into production during the first wave. Canada’s supply of its vaccine will be available in November. Pregnant women are being encouraged to get both vaccination shots.
Health Canada has ordered 50 million doses, enough to supply the Canadian population. Supply is expected in November.
Health Canada has recommended delaying the seasonal flu vaccination until January. While some provinces are administering it sooner, the MUHC is following Health Canada’s recommendation.
Each country has chosen its own strategy. Health Canada is confident that its supply and approach to mitigating the risks associated with the potential second wave of the H1N1 flu pandemic is appropriate.
There is no specific guideline per se though people who have been identified as having an increased risk, such as those with underlying health conditions and pregnant women, as well as frontline caregivers should be vaccinated first.
Vaccination is a voluntary process. However, the MUHC is endorsing vaccination. Healthcare professionals and all staff will be strongly urged to get their vaccination shot in November as soon as the supply is available. The MUHC will roll out its seasonal flu vaccine programme in January.
Yes. Two anti-viral drugs – Tamiflu and Relenza – have shown to be effective against the H1N1 flu virus. However, use is reserved for severe cases of flu or people in high-risk categories who become ill. Thus far, most patients recover at home by resting.
The MUHC has undertaken a comprehensive pandemic preparation, examining areas that could need bolstering, in particular ERs and ICUs. Communication and training efforts are MUHC-wide, with a focus on prevention, on timely updates and on preparedness. The vigilance that was adopted during the first wave will remain a priority.
The MUHC will provide timely communications to its community in order to separate fact from hype.

